NP0331994 | 3,4,5-Trihydroxy-7-megastigmen-9-one | | | C13H22O4
242.3150 Da 242.15181 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0331995 | Crocusatin B | | | C10H16O3
184.2350 Da 184.10994 Da | |
NP0331996 | 3-hydroxy-5α,6α-epoxy-β-ionone | | | C13H20O3
224.3000 Da 224.14124 Da | |
NP0331997 | 3-hydroxy-5β,6β-epoxy-β-ionone | | | C13H20O3
224.3000 Da 224.14124 Da | |
NP0331998 | trans-(3R,6R)-3-hydroxyl-α-ionylideneacetic acid | | | C15H22O3
250.3380 Da 250.15689 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0331999 | (Z)-2-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene) acetic acid | | | C11H18O4
214.2610 Da 214.12051 Da | 1H NMR Spectrum (1D, 600, C3D6O, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, C3D6O, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, C3D6O, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332000 | Tageteserectone A | | | C15H20O3
248.3220 Da 248.14124 Da | |
NP0332001 | Cyclo-(Phe-Ser) | | | C12H14N2O3
234.2550 Da 234.10044 Da | |
NP0332002 | Butyl (5R,6R,7S,8S)-5,6,7,8-tetrahydro-6,7,8-trihydroxy-5-(hydroxymethyl)imidazo[1,2-a]pyridine-2-carboxylate | | | C13H20N2O6
300.3110 Da 300.13214 Da | |
NP0332003 | Cyclo-(Val-Ala) | | | C8H14N2O2
170.2120 Da 170.10553 Da | |
NP0332004 | Methyl (5R,6R,7S,8S)-5,6,7,8-tetrahydro-6,7,8-trihydroxy-5-(hydroxymethyl)imidazo[1,2-a]pyridine-2 carboxylate | | | C10H14N2O6
258.2300 Da 258.08519 Da | |
NP0332005 | Cyclo-(Ala-Pro) | | | C8H12N2O2
168.1960 Da 168.08988 Da | |
NP0332006 | Cyclo-(Gly-Pro) | | | C7H10N2O2
154.1690 Da 154.07423 Da | |
NP0332008 | Aminosalicylic Acid | | | C7H7NO3
153.1354 Da 153.04259 Da | 1H NMR Spectrum (1D, 600, CD3OD, simulated) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332009 | 4-Quinolinol | | | C9H7NO
145.1580 Da 145.05276 Da | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332010 | Tetradecanol | | | C14H30O
214.3874 Da 214.22967 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 201 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0332011 | amphicordin A | | | C16H19ClO4
310.7700 Da 310.09719 Da | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0332012 | amphicordin C | | | C18H22O6
334.3680 Da 334.14164 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0332013 | amphicordin D | | | C19H26O7
366.4100 Da 366.16785 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0332014 | amphicordin B | | | C18H22O6
334.3680 Da 334.14164 Da | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
NP0332015 | Alstoboonine | | | C19H21N2O4
341.3860 Da 341.14958 Da | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
NP0332016 | Akunolide B (S)-MTPA ester at C-9 | | | C46H67F3O12
869.0250 Da 868.45846 Da | |
NP0332017 | Reducted akunolide A and B | | | C36H66O10
658.9140 Da 658.46560 Da | |
NP0332019 | Akunolide C | | | C35H58O10
638.8390 Da 638.40300 Da | [1H, 1H] NMR Spectrum (2D, 392 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 100 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 392 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 396 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 396 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 392 MHz, CD3OD, experimental) |
|
NP0332020 | Akunolide D | | | C35H60O10
640.8550 Da 640.41865 Da | 13C NMR Spectrum (1D, 99 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 396 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 392 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 396 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 396 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 396 MHz, CD3OD, experimental) |
|